Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cross-sectional Study to Evaluate the Chronic Kidney Disease Prevalence Using a Creatinine Point-of-care Tool in Brazilian Adult Patients With Known CKD Risk Factors Randomly Selected

NCT07103629 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT07103629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07103629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cross-sectional Study to Evaluate the Chronic Kidney Disease Prevalence Using a Creatinine Point-of-care Tool in Brazilian Adult Patients With Known CKD Risk Factors Randomly Selected
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
May 31, 2025
Completion date
September 30, 2025
Enrollment
8,428 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

renal insufficiency, chronic